Q: What is the MiniMed™ 780G system? A: It’s Medtronic’s most advanced automated insulin delivery system that automatically ...
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice ...
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
GlobalData on MSN
Medtronic achieves three milestones for MiniMed 780G system in US
Beneficiaries of Medicare and Medicare Advantage can now obtain the MiniMed 780G system combined with the Instinct sensor.
The US FDA has approved Medtronic’s 780G for use with rapid-acting insulin and with Abbott’s type 2 diabetes-specific sensor.
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...
By Mike Scarcella and Blake Brittain Feb 5 (Reuters) - Medtronic owes rival medical device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for ...
Feb 3 (Reuters) - Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as ...
Medical Device Network on MSN
Medtronic set to acquire CathWorks for $585M
The acquisition remains subject to US Federal Trade Commission clearance and other regulatory approvals.
In its announcement, Medtronic said it plans to move forward with the CathWorks acquisition in a transaction valued at up to ...
Just weeks after announcing it would "step up" its acquisitions this year, Medtronic said it will shell out up to ...
Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results